Skip to main content
Top

Bibliometric analysis of programmed cell death and immunogenic cell death in hepatocellular carcinoma immunotherapy: global trends and future directions

Published in:

Abstract

Purpose

Immunotherapy has become a prominent research focus in hepatocellular carcinoma (HCC) treatment, particularly through immunogenic cell death (ICD), a specialized form of programmed cell death (PCD), to enhance therapeutic efficacy. Although there is a wealth of research in this field, there is a lack of bibliometric analysis to fill the gap in understanding global research trends, key hotspots, and future research directions.

Methods

This study employed bibliometric analysis using data from the Web of Science database, analyzing 958 publications from 2000 to 2024. The inclusion criteria were: (1) articles and review articles published in English, and (2) studies focusing on the role of PCD and ICD in HCC immunotherapy. Publications that were not articles or review articles were excluded. Visualization tools such as VOSviewer, CiteSpace, and the bibliometrix R package were used.

Results

The analysis included 52 countries, 1,176 institutions, and 5,453 authors, with publications spread across 343 journals. Since 2020, research volume has surged, indicating increased academic interest in this area. China led in publication output, with Zhejiang University being the most prolific institution. Frontiers in Immunology published the highest number of articles, while Cancer Research had the highest number of co-citations. Feng Zhang was the most prolific author, while J-M. Llovet had the highest number of co-citations. Key research hotspots include PCD and ICD mechanisms, immune microenvironment, tumor immune evasion, drug resistance, adoptive immunotherapy, and combination therapies. Future studies are expected to focus on immune evasion, tumor microenvironment regulation, novel cell death mechanisms, and personalized immunotherapy.

Conclusion

This study analyzes the literature on the role of PCD and ICD in HCC immunotherapy, revealing global research trends and current hotspots, and provides valuable guidance for future research directions.
Title
Bibliometric analysis of programmed cell death and immunogenic cell death in hepatocellular carcinoma immunotherapy: global trends and future directions
Authors
Shan-Peng Chen
Jie Tian
Publication date
01-12-2025
Publisher
Springer US
Published in
Discover Oncology / Issue 1/2025
Print ISSN: 1868-8497
Electronic ISSN: 2730-6011
DOI
https://doi.org/10.1007/s12672-025-02278-9
This content is only visible if you are logged in and have the appropriate permissions.
This content is only visible if you are logged in and have the appropriate permissions.

Keynote webinar | Spotlight on progress in colorectal cancer

CRC remains a major global health burden, but advances in screening, treatment, and lifestyle-based prevention continue to reshape clinical practice. Gain insights into how the latest research can be leveraged to optimize patient care across the CRC continuum.

Prof. Antoni Castells
Prof. Harpreet Wasan
Prof. Edward Giovannucci
Watch now

Keynote webinar | Spotlight on functional neurological disorder

FND perplexes and frustrates patients and physicians alike. Limited knowledge and insufficient awareness delays diagnosis and treatment, and many patients feel misunderstood and stigmatized. How can you recognize FND and what are the treatment options?

Prof. Mark Edwards
Watch now
Video
Image Credits
Colon cancer illustration/© (M) KATERYNA KON / SCIENCE PHOTO LIBRARY / Getty Images, Human brain illustration/© (M) CHRISTOPH BURGSTEDT / SCIENCE PHOTO LIBRARY / Getty Images